1. Home
  2. TFX vs WGS Comparison

TFX vs WGS Comparison

Compare TFX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$109.97

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$138.63

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFX
WGS
Founded
1943
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TFX
WGS
Price
$109.97
$138.63
Analyst Decision
Hold
Strong Buy
Analyst Count
10
8
Target Price
$139.88
$138.13
AVG Volume (30 Days)
732.0K
382.0K
Earning Date
02-26-2026
02-17-2026
Dividend Yield
1.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$3,189,988,000.00
$402,190,000.00
Revenue This Year
$9.90
$41.17
Revenue Next Year
$10.51
$23.53
P/E Ratio
N/A
$1,869.35
Revenue Growth
5.42
50.50
52 Week Low
$102.58
$55.17
52 Week High
$185.94
$170.87

Technical Indicators

Market Signals
Indicator
TFX
WGS
Relative Strength Index (RSI) 33.05 48.02
Support Level $108.39 $124.26
Resistance Level $127.49 $138.73
Average True Range (ATR) 3.05 5.52
MACD -1.50 0.23
Stochastic Oscillator 10.79 69.60

Price Performance

Historical Comparison
TFX
WGS

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: